associatedwithacutekidneyinjuryandtherisk
ofchronickidneydisease.KidneyInt.2017.
48.GreenbergJH,ZappitelliM,DevarajanP,etal.
Kidneyoutcomes5yearsafterpediatriccardiac
surgery:theTRIBE-AKIstudy.JAMAPediatr.
2016;170(11):1071–1078.
49.GoldsteinSL,JaberBL,FaubelS,ChawlaLS.
AcutekidneyinjuryadvisorygroupofAmerican
societyofN.AKItransitionofcare:apotential
opportunitytodetectandpreventCKD.ClinJ
AmSocNephrol.2013;8(3):476–483.
50.SilverSA,GoldsteinSL,HarelZ,etal.
Ambulatorycareafteracutekidneyinjury:an
opportunitytoimprovepatientoutcomes.CanJ
KidneyHealthDis.2015;2:36.
51.ChawlaLS,BellomoR,BihoracA,etal.Acute
kidneydiseaseandrenalrecovery:consensus
reportoftheacutediseasequalityinitiative
(ADQI)16workgroup.NatRevNephrol.
2017;13(4):241–257.
52.AlgeJL,ArthurJM.BiomarkersofAKI:a
reviewofmechanisticrelevanceandpotential
therapeuticimplications.ClinJAmSocNephrol.
2015;10(1):147–155.
53.KrawczeskiCD,GoldsteinSL,WooJG,etal.
Temporalrelationshipandpredictivevalueof
urinaryacutekidneyinjurybiomarkersafter
pediatriccardiopulmonarybypass.JAmColl
Cardiol.2011;58(22):2301–2309.
54.ZappitelliM,KrawczeskiCD,DevarajanP,etal.
EarlypostoperativeserumcystatinCpredicts
severeacutekidneyinjuryfollowingpediatric
cardiacsurgery.KidneyInt.2011;80(6):655–
662.
55.ParikhCR,DevarajanP,ZappitelliM,etal.
Postoperativebiomarkerspredictacutekidney
injuryandpooroutcomesafterpediatriccardiac
surgery.JAmSocNephrol.2011;22(9):1737–
1747.
56.GistKM,GoldsteinSL,WronaJ,etal.Kinetics
ofthecellcyclearrestbiomarkers(TIMP2*IGFBP-7)forpredictionofacutekidney
injuryininfantsaftercardiacsurgery.Pediatr
Nephrol.2017.
57.BasuRK,WongHR,KrawczeskiCD,etal.
Combiningfunctionalandtubulardamage
biomarkersimprovesdiagnosticprecisionfor
acutekidneyinjuryaftercardiacsurgery.JAm
CollCardiol.2014;64(25):2753–2762.
58.RicciZ,LucianoR,FaviaI,etal.High-dose
fenoldopamreducespostoperativeneutrophil
gelatinase-associatedlipocalineandcystatinC
levelsinpediatriccardiacsurgery.CritCare.
2011;15(3):R160.
59.GoldsteinSL.Anovelusefornovelacutekidney
injurybiomarkers:fenoldopam'seffecton
neutrophilgelatinase-associatedlipocalinand
cystatinC.CritCare.2011;15(4):177.
60.HeywoodJT,FonarowGC,CostanzoMR,etal.
Highprevalenceofrenaldysfunctionandits
impactonoutcomein118,465patients
hospitalizedwithacutedecompensatedheart
failure:areportfromtheADHEREdatabase.J
CardFail.2007;13(6):422–430.
61.JefferiesJL,GoldsteinSL.Cardiorenal
[corrected]syndrome:anemergingproblemin
pediatriccriticalcare.PediatrNephrol.
2013;28(6):855–862.
62.PriceJF,MottAR,DickersonHA,etal.
Worseningrenalfunctioninchildren
hospitalizedwithdecompensatedheartfailure:
evidenceforapediatriccardiorenalsyndrome?
PediatrCritCareMed.2008;9(3):279–284.
63.KaddourahA,GoldsteinSL,LipshultzSE,etal.
Prevalence,predictors,andoutcomesof
cardiorenalsyndromeinchildrenwithdilated
cardiomyopathy:areportfromthepediatric
cardiomyopathyregistry.PediatrNephrol.
2015;30(12):2177–2188.
64.CostanzoMR,RoncoC,AbrahamWT,etal.
Extracorporealultrafiltrationforfluidoverload